Sdi Share Discussion Threads

[nick2008] 23/2/2013 15:41

Slow and steady rise here. Another 10% up. From Dec 2012 it was 11p to now 26p. 136% rise.

More to come....

[nick2008] 12/2/2013 11:56

In Dec-12, Synoptics Health launch the ProReveal (See header for details), then we saw Artemis (another SDI subsidiary ) launching 11 megapixel CCD ()

Well! It seems they are launching more new products - See the news below - this time from their Syngene subsidiary . Seems like the new CEO is really making his presence felt.


Syngene Launches PXi Touch Range of Versatile Image Analysis Systems
publication date: Jan 28, 2013



Related article -
Gel Documentation Systems Grow More Sophisticated Tuesday, December 18, 2012


Gel documentation systems might not warrant the ooohs and aaahs of, say, a synchrotron. But gel documentation systems, also called gel imaging systems, are relied upon by vastly more researchers and play a pivotal role in more research projects than the noble synchrotron.

The ultimate form of ease of use is automation, which is where many gel documentation systems are headed today.

For example, Syngene offers a new line of smaller, more compact gel documentation systems called PXi. Along with Syngene's gel imagers comes the devices' acquisition software, GeneSys. This is the brain that runs the automated tasks for you.

"Before this program, users needed to know exactly how to image their sample-including exposure time, light settings, filter settings, camera settings-in order to get the best image," says Maggie Pochyla, U.S. market manager for Syngene.

"GeneSys eliminates that need and automatically captures an image perfectly, even if the user is unaware of what lights, filters and exposure time to use." Such a system is especially useful in labs with younger students.

The image acquisition and analysis software should be intuitive and easy to use so that even if [users have] no prior imaging experience, they can easily operate the software and system," she says. Syngene's G:BOX and PXi gel documentation systems include automation of the camera and hardware controls

[hastings] 11/2/2013 12:36

Still off the radar for many.

[nick2008] 11/2/2013 12:33

That's some buying going on !

Like everyone's woken up to Fridays RNS just now......

[nick2008] 08/2/2013 09:52

Synbiosis division - one which won this contract - is expected to grow significantly this year. If this starts to contribute as much as the largest division syngene, then we are talking about better than expected profits this year.....


Synbiosis from Post 5
- First on the market to generate antibiotic and vaccine potency analysis automatically from count and zone data providing a distinct competitive advantage.
- Like the Syngene market space, the trend is to purchase low-cost products, so they have both low entry and high end products available.
- Their high end-colony counter and zone sizing system ProtoCOL 3 has been introduced this year and is modular, so offers a cost-effective purchase to customers.
- Last year received their single largest order since inception to install 27 ProtoCOL 3 systems on behalf of UNICEF.

[nick2008] 08/2/2013 07:49

Commenting on the news SDI's Chairman, Ken Ford, stated: "Selling the ProtoCOL 3 systems to the Chinese equivalent of the FDA is a coup. Our technology was in a rigorous tender process against systems from 10 other US, European and Chinese companies so to come out on top is a boost, not just for our Synbiosis Division, but also for other life science firms in Cambridge's Innovation hub."

SDI product & technology better than most other across continents - and with new CEO it's all happening for this stock this year.

[nick2008] 08/2/2013 07:42

Wake up Guys,

RNS out for sales to Chinese Govt

Nick

[nick2008] 07/2/2013 13:36

Indeed, Hasting

For me, the best sales initiative for their new product ProReveal is to appoint Peskett Solutions Ltd as the sole UK Distributor.

- Peskett Solutions currently are the sole UK distributor for world market leader company RUHOF whose cleaning liquid is used in almost all sterile services departments within UK hospitals and globally.
- Peskett Solutions are best placed to sell the Synoptics protein detection equipment due to their current product range as they have access to the hospital managers within sterile services departments.
- These managers not only just recommend a product but also have the budgets allocated to buy the products and services appropriate to their departments.


ProReveal product is 100 times more senstive than the current tests, so I'm sure RUHOF would have heard about it through their own UK Distributor - Peskett Solutions.

There is no conflict of interest between RUHOF & SDI. RUHOF's product is used for cleaning the instruments and SDI detects the protein on them after cleaning. If the cleaning is below a certain threshold, then all the instruments have to be cleaned again using RUHOF cleaning product.

RUHOF is large organisation with worldwide dealers and distribution centres. I won't surprised if RUHOF themselves would be keen to sell SDI products outside UK, using their own channels....

Nick

[hastings] 07/2/2013 12:40

Yes Nick, i think you will find that those shares were placed in good hands.

[nick2008] 07/2/2013 10:27

Started a New Thread

[nick2008] 07/2/2013 10:24

Started a New Thread

[nick2008] 07/2/2013 10:07

Hastings
Yeap! noted the Non exec Director is an ex Dialight and bought stock twice last year!

House broker target is conservative as mgt haven't' revised it yet for revenues from their new first mover competitive advantage product - ProReveal. Once they get a 'feel' for the demand, the forecast and target will be revised north of 40p.

Someone I know reckons this will be £4 within 3-4 years!

DYOR, Nick

[hastings] 06/2/2013 19:35

Hi Nick, an interesting off the radar Company. FLoated back in 2008 at what was probably not the best of timing! Some interesting Institutions including the BP Pension Fund took a punt and very little happened. However, things stirring here and with a very, very small shareholder base,coupled with limited shares in issue, any real growth in profits will translate into serious Eps appreciation.
Non exec Director an ex Dialight and quite shrewd player bought shares prior to the recent spike, but could be a lot more to come. House Broker has a 40p target price for anyone interested.

[nick2008] 06/2/2013 15:56

26,070 Buys vs 3,821 sells as of now....

[nick2008] 06/2/2013 10:35

Artemis (subsidiary of Scientific Digital Imaging plc) launches 11 megapixel CCD scientific camera for low light imaging - 26th Jan 2013

[nick2008] 05/2/2013 18:55

Welcome Hastings - excellent find, I'm here especially for ProReveal product.

Good to see trades. I think we will see more this month.


DYOR,
Nick.

[nick2008] 04/2/2013 00:36

Recent news articles

1.

2.

3.

4.

5.

[nick2008] 04/2/2013 00:36

Second Subsidiary - Atik Cameras

- Atik manufactures high-sensitivity cameras for deep-sky astronomical and life science imaging
- Focused to increase its share of the amateur astronomy market and to prepare for increasing activity in the scientific and OEM sectors
- Discretionary consumer spending, including hobbies such as astronomy, is under pressure. This is particularly true of Atik's core market in Europe where competition comes from brands originating from East and West. Atik is resisting the pressure to move to niche high-end products and continues to offer high quality, affordable products to main-stream astronomers
- During the year Atik was able to introduce a new camera platform named the 4 series. The platform supports a number of high resolution Sony sensors
- Interest is growing in North America due to promotion of the brand through advertising campaigns over a period of several years which is translating into a significant number of sales in America
- Several new OEM relationships were established during the period.

[nick2008] 04/2/2013 00:36

3. Syncroscopy

- Main product is Auto-Montage, a software package that allows customers to overcome the limited depth of field in an optical microscope.
- Market is fragmented and difficult to quantify because of the wide range of applications. Major microscope suppliers, including Olympus, Nikon, Zeiss and Leica Microsystems ("Leica"), now offer digital cameras and associated software with their microscopes.
- Syncroscopy does not aim to compete in this 'mainstream' and highly competitive market and, in order to differentiate its offering, has created a successful relationship with Leica which offers a version of the Syncroscopy Auto-Montage product as an optional module for its flagship Leica Application Suite software.
- Auto-Montage is also offered directly and via distributors.

[nick2008] 04/2/2013 00:36

2. Synbiosis

- First on the market to generate antibiotic and vaccine potency analysis automatically from count and zone data providing a distinct competitive advantage.
- Like the Syngene market space, the trend is to purchase low-cost products, so they have both low entry and high end products available.
- Their high end-colony counter and zone sizing system ProtoCOL 3 has been introduced this year and is modular, so offers a cost-effective purchase to customers.
- Last year received their single largest order since inception to install 27 ProtoCOL 3 systems on behalf of UNICEF.

[nick2008] 04/2/2013 00:36

1. Syngene
Syngene is the largest of the three Synoptics brands and offers a more integrated range of equipment and consumables, which is preferred by scientists ensuring steady flow of sales volume. Last year, the PXi ("Pixie") was launched, a new high-end gel documentation system, with positive feedback particularly in Asia, where lab space is at a premium and smaller format gels are routinely used in research. Syngene also repositioned two products to introduce new mid-range products with improved gross margins.

However, recently the market has shifted towards the lower end of the cost spectrum with more competition with a consequent impact on the margin. Syngene have addressed this by re-engineering the low end products to attract a more favourable margin.

The market in the UK and Europe is showing slow but steady growth, and high growth in Asia especially in China.

Sales initiatives:
- Recently invested in two dedicated sales people for the UK and Europe,
- Encouraging performance in the Asian market
- In the US, continuing efforts to build the Syngene brand
- Strengthening their representation in South America and in Canada